More Globe Newswire

View Older Stories View Newer Stories

Nov 25, 2025 04:00AM Director/PDMR Dealings
Nov 25, 2025 03:58AM Form 8.3 - [IDOX PLC - 24 11 2025] - (CGWL)
Nov 25, 2025 03:57AM LIPULS Launches Three New 12V LiFePO4 Batteries for Black Friday
Nov 25, 2025 03:56AM Form 8.3 - [IQE PLC - 24 11 2025] - (CGAML)
Nov 25, 2025 03:55AM Zhihu Inc. Reports Unaudited Third Quarter 2025 Financial Results
Nov 25, 2025 03:45AM Changan Makes Official Debut at São Paulo Auto Show, Launches Brand in Brazil
Nov 25, 2025 03:34AM YourSecret Updates Launch Timeline and Reveals Redesigned Anonymous Social Platform
Nov 25, 2025 03:31AM 54/2025・Trifork Group: Reporting of transactions made by persons discharging managerial responsibilities
Nov 25, 2025 03:30AM CONDITIONS FOR SALE OF RIKSBANK CERTIFICATES
Nov 25, 2025 03:24AM The upcoming 3rd Overseas Chinese Talent Conference for Development to unveil multiple innovative outcomes
Nov 25, 2025 03:23AM Onyen Corporation Releases Case Studies Demonstrating Quantifiable Improvements in Global Risk, Sustainability, and Compliance Reporting
Nov 25, 2025 03:15AM Form 8.5 (EPT/RI)-NCC Group plc
Nov 25, 2025 03:15AM The 4th Gannan Navel Orange International Expo inaugurated grandly at the E-commerce Express Logistics Park in Anyuan County, Jiangxi Province
Nov 25, 2025 03:11AM Lushan is making efforts to enhance the experience of international tourists and attract more people to travel here through photography events
Nov 25, 2025 03:00AM Repeat: Vantage Drilling International Ltd. Schedules Third Quarter of 2025 Earnings Release Date and Conference Call
Nov 25, 2025 03:00AM Kalmar to supply forklift truck fleet including next-generation lithium-ion battery solution to ArcelorMittal
Nov 25, 2025 03:00AM Issue of Equity and Total Voting Rights
Nov 25, 2025 03:00AM Issue of Equity and Total Voting Rights
Nov 25, 2025 02:55AM 2025 Jingdezhen Prize has been announced: Revealing the Future of Handicraft
Nov 25, 2025 02:49AM ChoiceLifeQuote.com Integrates Technology and Service for Life Insurance Consumers
Nov 25, 2025 02:30AM Euronext announces the results of the tender offer on existing EUR 2026 Bonds
Nov 25, 2025 02:30AM Allegro and American Regent sign exclusive licensing deal for SynoglideTM, a novel osteoarthritis treatment in animal health, valued at up to $35 million
Nov 25, 2025 02:25AM RAMSAY SANTE : Press release on November 25 2025
Nov 25, 2025 02:00AM WENDEL: Signing of the acquisition agreement of Committed Advisors
Nov 25, 2025 02:00AM STMicroelectronics streamlines smart-home device integration with industry-first Matter NFC chip
Nov 25, 2025 02:00AM Caledonia Mining Corporation Plc: Publication and Highlights of the Feasibility Study for Bilboes Gold Project
Nov 25, 2025 02:00AM Equinor ASA: Share buy-back – fourth tranche for 2025
Nov 25, 2025 02:00AM NBPE Announces Transaction in Own Shares
Nov 25, 2025 02:00AM Director/PDMR Shareholding
Nov 25, 2025 02:00AM OSB GROUP PLC - Transaction in Own Shares
Nov 25, 2025 02:00AM Transaction in Own Shares
Nov 25, 2025 02:00AM Progress on share buyback programme
Nov 25, 2025 02:00AM Elis: Disclosure of trading in own shares occured from November 18 to November 21, 2025
Nov 25, 2025 02:00AM Dividend payment ex-date of Aktsiaselts Infortar
Nov 25, 2025 01:26AM TCM Group A/S: Interim report Q3 2025
Nov 25, 2025 01:15AM Novartis data underscore pioneering scientific innovation in Hematology and Oncology at ASH and SABCS
Nov 25, 2025 01:30AM Mowi ASA – Green Bond Mandate Announcement and Fixed Income Investor Meetings
Nov 25, 2025 01:30AM Sampo plc’s share buybacks 24 November 2025
Nov 25, 2025 01:02AM ABN AMRO to sell Alfam to Rabobank
Nov 25, 2025 01:00AM Dupixent® (dupilumab) Approved as the First Targeted Medicine in the European Union (EU) in Over a Decade for Chronic Spontaneous Urticaria (CSU)
Nov 25, 2025 01:00AM Dupixent® (dupilumab) Approved as the First Targeted Medicine in the European Union (EU) in Over a Decade for Chronic Spontaneous Urticaria (CSU)
Nov 25, 2025 01:00AM ABN AMRO presents roadmap for profitable growth and new financial targets for 2028
Nov 25, 2025 01:00AM Start of Day Message
Nov 25, 2025 01:00AM Sanoma updates its financial targets – aims to deliver high single-digit growth in the Group’s adjusted operating profit in 2026–2030
Nov 25, 2025 01:00AM Press Release: Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria
Nov 25, 2025 01:00AM Arcadis reports transactions under its current share buyback program
Nov 25, 2025 01:00AM Weekly progress on share repurchase program to cover share plans and reduce capital
Nov 25, 2025 01:00AM Vivoryon Therapeutics N.V. to Report Q3 2025 Financial Results and Operational Progress on December 4, 2025
Nov 25, 2025 12:39AM atom11 Wins the AI Innovation Award at Amazon Partner Awards 2025
Nov 25, 2025 12:01AM Global Panda Partners Conference 2025 Commences in Shuangliu District, Chengdu
View Newer Stories View Older Stories